Chronic β-adrenergic stimulation reverses depressed Ca handling in mice overexpressing inhibitor-2 of protein phosphatase 1. (December 2018)
- Record Type:
- Journal Article
- Title:
- Chronic β-adrenergic stimulation reverses depressed Ca handling in mice overexpressing inhibitor-2 of protein phosphatase 1. (December 2018)
- Main Title:
- Chronic β-adrenergic stimulation reverses depressed Ca handling in mice overexpressing inhibitor-2 of protein phosphatase 1
- Authors:
- Kirchhefer, Uwe
Hammer, Elke
Heinick, Alexander
Herpertz, Thomas
Isensee, Gunnar
Müller, Frank U.
Neumann, Joachim
Schulte, Kirsten
Seidl, Matthias D.
Boknik, Peter
Schulte, Jan S. - Abstract:
- Abstract: Rationale: A higher expression/activity of type 1 serine/threonine protein phosphatase 1 (PP1) may contribute to dephosphorylation of cardiac regulatory proteins triggering the development of heart failure. Objective: Here, we tested the putatively protective effects of PP1 inhibitor-2 (I2 ) overexpression using a heart failure model induced by chronic β-adrenergic stimulation. Methods and results: Transgenic (TG) and wild-type (WT) mice were subjected to isoprenaline (ISO) or isotonic NaCl solution supplied via osmotic minipumps for 7 days. I2 overexpression was associated with a depressed PP1 activity. Basal contractility was unchanged in catheterized mice and isolated cardiomyocytes between TG NaCl and WT NaCl . TG ISO mice exhibited more fibrosis and a higher expression of hypertrophy marker proteins as compared to WT ISO . After acute administration of ISO, the contractile response was accompanied by a higher sensitivity in TG ISO as compared to WT ISO . In contrast to basal contractility, the peak amplitude of [Ca]i and SR Ca load were reduced in TG NaCl as compared to WT NaCl . These effects were normalized to WT levels after chronic ISO stimulation. Cardiomyocyte relaxation and [Ca]i decay kinetics were hastened in TG ISO as compared to WT ISO, which can be explained by a higher phospholamban phosphorylation at Ser 16 . Chronic catecholamine stimulation was followed by an enhanced expression of GSK3β, whereas the phosphorylation at Ser 9 was lower in TG asAbstract: Rationale: A higher expression/activity of type 1 serine/threonine protein phosphatase 1 (PP1) may contribute to dephosphorylation of cardiac regulatory proteins triggering the development of heart failure. Objective: Here, we tested the putatively protective effects of PP1 inhibitor-2 (I2 ) overexpression using a heart failure model induced by chronic β-adrenergic stimulation. Methods and results: Transgenic (TG) and wild-type (WT) mice were subjected to isoprenaline (ISO) or isotonic NaCl solution supplied via osmotic minipumps for 7 days. I2 overexpression was associated with a depressed PP1 activity. Basal contractility was unchanged in catheterized mice and isolated cardiomyocytes between TG NaCl and WT NaCl . TG ISO mice exhibited more fibrosis and a higher expression of hypertrophy marker proteins as compared to WT ISO . After acute administration of ISO, the contractile response was accompanied by a higher sensitivity in TG ISO as compared to WT ISO . In contrast to basal contractility, the peak amplitude of [Ca]i and SR Ca load were reduced in TG NaCl as compared to WT NaCl . These effects were normalized to WT levels after chronic ISO stimulation. Cardiomyocyte relaxation and [Ca]i decay kinetics were hastened in TG ISO as compared to WT ISO, which can be explained by a higher phospholamban phosphorylation at Ser 16 . Chronic catecholamine stimulation was followed by an enhanced expression of GSK3β, whereas the phosphorylation at Ser 9 was lower in TG as compared to the corresponding WT group. This resulted in a higher I2 phosphorylation that may reactivate PP1. Conclusion: Our findings suggest that the basal desensitization of β-adrenergic signaling and the depressed Ca handling in TG by inhibition of PP1 is restored by a GSK3β-dependent phosphorylation of I2 . … (more)
- Is Part Of:
- Journal of molecular and cellular cardiology. Volume 125(2018)
- Journal:
- Journal of molecular and cellular cardiology
- Issue:
- Volume 125(2018)
- Issue Display:
- Volume 125, Issue 2018 (2018)
- Year:
- 2018
- Volume:
- 125
- Issue:
- 2018
- Issue Sort Value:
- 2018-0125-2018-0000
- Page Start:
- 195
- Page End:
- 204
- Publication Date:
- 2018-12
- Subjects:
- Protein phosphatase 1 -- Inhibitor-2 -- Heart failure -- β-adrenergic stimulation -- Ca handling
Cardiology -- Periodicals
Heart Diseases -- Periodicals
Molecular Biology -- Periodicals
Cardiologie -- Périodiques
Cardiology
Electronic journals
Periodicals
616.12 - Journal URLs:
- http://www.sciencedirect.com/science/journal/00222828 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00222828 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/00222828 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.yjmcc.2018.10.022 ↗
- Languages:
- English
- ISSNs:
- 0022-2828
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5020.690000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11755.xml